Increased urinary excretion of IgM can predict development of end-stage renal disease (ESRD) and mortality associated with cardiovascular events in patients with type 1 diabetes mellitus, according to ...
High levels of immunoglobulin M (IgM) in the urine of diabetic patients may predict development of end-stage renal disease (ESRD) and death from cardiovascular disease (CVD), independent of ...
Effect of inhibition of PARP-1 on mantle cell lymphoma cells with dysfunctional ATM No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2008 ASCO Annual ...
MOUNTAIN VIEW, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results